MedPath

金陵药业股份有限公司南京金陵制药厂

Ownership
-
Established
1996-09-16
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

179

NMPA:179

Drug Approvals

Magnesium Sulfate Injection

Product Name
硫酸镁注射液
Approval Number
国药准字H20249697
Approval Date
Dec 6, 2024
NMPA

Compound Sulfamethoxazole Injection

Product Name
复方磺胺甲噁唑注射液
Approval Number
国药准字H20247150
Approval Date
Jul 1, 2024
NMPA

Levofloxacin Hydrochloride Capsules

Product Name
盐酸左氧氟沙星胶囊
Approval Number
国药准字H20073876
Approval Date
Feb 11, 2022
NMPA

Isosorbide Mononitrate Injection

Product Name
单硝酸异山梨酯注射液
Approval Number
国药准字H20073693
Approval Date
Feb 11, 2022
NMPA

Dexamethasone Sodium Phosphate Injection

Product Name
地塞米松磷酸钠注射液
Approval Number
国药准字H32021839
Approval Date
Dec 25, 2020
NMPA

板蓝根颗粒

Approval Number
国药准字Z32021116
Approval Date
Dec 25, 2020
NMPA

Berberine Hydrochloride Tablets

Product Name
盐酸小檗碱片
Approval Number
国药准字H32023164
Approval Date
Dec 25, 2020
NMPA

Inosine Tablets

Product Name
肌苷片
Approval Number
国药准字H32023162
Approval Date
Dec 25, 2020
NMPA

Nicardipine Hydrochloride Injection

Product Name
盐酸尼卡地平注射液
Approval Number
国药准字H20066481
Approval Date
Dec 25, 2020
NMPA

Berberine Hydrochloride Tablets

Product Name
盐酸小檗碱片
Approval Number
国药准字H32023165
Approval Date
Dec 25, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 18
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.